Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 78.70
-2.90 (-3.55%)
At close: Sep 11, 2026
Acrobiosystems Market Cap
Acrobiosystems has a market cap or net worth of 13.16 billion as of September 11, 2026. Its market cap has increased by 29.27% in one year.
Market Cap
13.16B
Enterprise Value
12.17B
Revenue
950.35M
Ranking
n/a
PE Ratio
72.01
Stock Price
78.70
ChartMarket Cap Chart
Since October 18, 2021, Acrobiosystems's market cap has decreased from 13.51B to 13.16B, a decrease of -2.58%. That is a compound annual growth rate of -0.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 13.16B | 45.55% |
| Dec 31, 2025 | 9.04B | 71.05% |
| Dec 31, 2024 | 5.28B | -25.26% |
| Dec 29, 2023 | 7.07B | -13.93% |
| Dec 30, 2022 | 8.22B | -51.36% |
| Dec 31, 2021 | 16.89B | 25.06% |
| Oct 18, 2021 | 13.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yili Chuanning Biotechnology | 18.42B |
| Sinocelltech Group | 16.00B |
| BrightGene Bio-Medical Technology | 16.00B |
| Anhui Anke Biotechnology (Group) | 13.75B |
| Jinyu Bio-technology | 13.30B |
| HitGen | 12.98B |
| GemPharmatech | 12.94B |
| Shanghai Medicilon | 12.72B |